News

A new study published in the journal JAMA Otolaryngology–Head & Neck Surgery has found that deficits in the sense of smell, ...
Medicine to treat one thing may unintentionally help another -- but one vaccine is pulling triple duty for body, mind and ...
The only actual available "test" for Alzheimer’s disease in younger people would be to check someone's APOE 4 levels, which ...
A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.
Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 RAs may help prevent the disease.
Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Over 6 million Americans are impacted by Alzheimer's disease, and researchers from Vanderbilt University Medical Center and the University of Pittsburgh are discovering how lifestyle habits can impact ...
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Are we promoting prevention strategies that work for everyone, or only for those who already have the means and access?
In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions.